Gubra

Biotechnology Research • Hørsholm, Capital Region of Denmark, Denmark • 201-500 Employees

Company overview

Headquarters	Hørsholm Kongevej 11b, Hoersholm, 2970, DK
Phone number	+4531522650
Website	gubra.dk
NAICS	541714
SIC	873
Keywords	Obesity, Diabetes, Imaging, Bioinformatics, Next Generation Sequencing, Histology, Nash, Stereology, In Vivo Pharmacology, Peptide Chemistry, Ex Vivo Assays, Molecular Pharmacology, Gastrointestinal Diseases
Founded	2008
Employees	201-500
Socials

Emails Format About Revenue Employees Insights Funding Tech Stack Trending Companies FAQ

Gubra Email Formats

Gubra uses 2 email formats. The most common is {2char} (e.g., {2char}@gubra.dk), used 97.1% of the time.

Format	Example	Percentage
{2char}	{2char}@gubra.dk	97.1%
{first name}	john@gubra.dk	2.9%

About Gubra

Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, MASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across the world in the pharmaceutical and biotech industry as well as academia. Through a constant focus on high quality, scientific excellence, speed and solid teamwork, we have established ourselves as a highly professional and competent partner in the market.

Gubra revenue & valuation

Annual revenue	$32,500,000
Revenue per employee	$115,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$104,000,000
Total funding	No funding